- Filed
- Oct 23, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 20, 2025 | 16.21M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 16.61M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 16.51M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 16.34M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 16.29M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $106.4M |
| Capex | Q3 2025 · Sep 30, 2024 | $124.8M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $132M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $123.7M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $1.04B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $1.04B |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $17.2M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $18.4M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $45.7M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $806.1M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $776M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $756.8M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $743.1M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $729.4M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $727.6M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $714.7M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $652.2M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $500.7M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $400.5M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.79B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.67B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $1.24B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $1.07B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $2.59B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $2.41B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $2.38 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $5.10 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.54 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $2.81 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.44 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $5.22 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $0.54 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $2.85 |
| Net Income | Q3 2025 · Sep 30, 2025 | $39.5M |
| Net Income | Q3 2025 · Sep 30, 2025 | $84.3M |
| Net Income | Q3 2025 · Jun 30, 2025 | $23.2M |
| Net Income | Q3 2025 · Mar 31, 2025 | $21.6M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $8.8M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $45.9M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | $18.9M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | $18.2M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $48.8M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $128.2M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $13.2M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $73.7M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $728.8M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.13B |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $676M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $2B |
| Revenue | Q3 2025 · Sep 30, 2025 | $843.5M |
| Revenue | Q3 2025 · Sep 30, 2025 | $2.44B |
| Revenue | Q3 2025 · Sep 30, 2024 | $747.7M |
| Revenue | Q3 2025 · Sep 30, 2024 | $2.26B |